Table of Content

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 17
1.2.1 MARKET SCOPE 17
1.2.2 YEARS CONSIDERED FOR THE STUDY 18
1.3 CURRENCY 18
1.4 LIMITATIONS 18
1.5 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.2 RESEARCH APPROACH 19
2.2.1 SECONDARY DATA 20
2.2.1.1 Key data from secondary sources 20
2.2.2 PRIMARY DATA 21
2.3 MARKET SIZE ESTIMATION 22
2.3.1 BOTTOM-UP APPROACH 23
2.3.2 TOP-DOWN APPROACH 24
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 30
4.1 BIOFILMS TREATMENT MARKET OVERVIEW 30
4.2 BIOFILMS TREATMENT MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 31
4.3 BIOFILMS TREATMENT MARKET SHARE, BY END USER, 2020 VS. 2025 31
4.4 BIOFILMS TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32

5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 33
5.2.1.1 Growing prevalence of chronic, surgical, and traumatic wounds 33
5.2.1.1.1 High incidence of obesity 33
5.2.1.1.2 Growing geriatric population 34
5.2.1.1.3 Increasing prevalence of diabetes 34
5.2.1.1.4 Increase in the number of surgical wounds and SSIs 34
5.2.1.1.5 Increasing number of traumatic wounds 35
5.2.1.2 Increasing incidence of burn injuries 35
5.2.2 OPPORTUNITIES 35
5.2.2.1 Growth potential in emerging economies 35
5.2.3 CHALLENGES 36
5.2.3.1 High cost and low adoption rate of advanced wound care products 36

6 BIOFILMS TREATMENT MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 DEBRIDEMENT EQUIPMENT 39
6.2.1 DEVELOPMENT OF NOVEL TECHNOLOGIES TO SUPPORT MARKET GROWTH 39
6.3 GAUZES AND DRESSINGS 41
6.3.1 GAUZES AND DRESSINGS ARE DESIGNED TO PREVENT THE OCCURRENCE OF INFECTIONS AFTER DEBRIDEMENT PROCEDURES 41
6.4 GRAFTS AND MATRICES 43
6.4.1 GRAFTS AND MATRICES PROMOTE HEALING AND WOUND CLOSURE 43
6.5 WIPES, PADS, AND LAVAGE SOLUTIONS 45
6.5.1 LAVAGE SOLUTIONS ARE USED FOR CLEANING WOUNDS DURING HYDRO SURGICAL AND MECHANICAL DEBRIDEMENT PROCEDURES 45
6.6 GELS, OINTMENTS, AND SPRAYS 48
6.6.1 THESE PRODUCTS ARE USED TO TREAT BURNS, DIABETIC FOOT ULCERS, AND SURGICAL & TRAUMATIC WOUNDS 48

7 BIOFILMS TREATMENT MARKET, BY WOUND TYPE 50
7.1 INTRODUCTION 51
7.2 SURGICAL AND TRAUMATIC WOUNDS 51
7.2.1 GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED TO SUPPORT MARKET GROWTH 51
7.3 DIABETIC FOOT ULCERS 52
7.3.1 RISING PREVALENCE OF DIABETES IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT 52
7.4 PRESSURE ULCERS 53
7.4.1 GERIATRIC POPULATION IS MORE SUSCEPTIBLE TO DEVELOPING PRESSURE ULCERS 53
7.5 VENOUS LEG ULCERS 54
7.5.1 INCREASING PREVALENCE OF OBESITY TO SUPPORT MARKET GROWTH 54
7.6 BURNS & OTHER OPEN WOUNDS 55
7.6.1 INCIDENCE OF BURN INJURIES IS HIGH IN EMERGING COUNTRIES 55

8 BIOFILMS TREATMENT MARKET, BY END USER 57
8.1 INTRODUCTION 58
8.2 HOSPITALS, ASCS, AND WOUND CARE CENTERS 58
8.2.1 RISING INCIDENCE OF HOSPITAL-ACQUIRED PRESSURE ULCERS AND INFECTIONS TO SUPPORT MARKET GROWTH 58
_
8.3 HOME CARE SETTINGS 59
8.3.1 RISING PREFERENCE FOR HOME HEALTHCARE IS CONTRIBUTING TO
THE GROWTH OF THIS MARKET 59
8.4 OTHER END USERS 60

9 BIOFILMS TREATMENT MARKET, BY REGION 61
9.1 INTRODUCTION 62
9.2 NORTH AMERICA 63
9.2.1 US 66
9.2.1.1 Rising prevalence of diabetes and favorable reimbursement policies in the country to boost the market growth 66
9.2.2 CANADA 68
9.2.2.1 Increasing government support to boost market growth 68
9.3 EUROPE 69
9.3.1 UK 71
9.3.1.1 Increase in R&D activities to propel market growth in the UK 71
9.3.2 GERMANY 73
9.3.2.1 Increasing incidence of diabetes will boost the market growth in Germany 73
9.3.3 RUSSIA 74
9.3.3.1 Government focus on increasing diabetes awareness will favor market growth in Russia 74
9.3.4 FRANCE 75
9.3.4.1 Rising geriatric population to drive the demand for advanced wound care products in the country 75
9.3.5 ITALY 77
9.3.5.1 Unfavorable reimbursement scenario for advanced wound care will hinder market growth in Italy 77
9.3.6 SPAIN 78
9.3.6.1 Rising geriatric population in the country to support market growth 78
9.3.7 REST OF EUROPE 80
9.4 ASIA PACIFIC 81
9.4.1 CHINA 84
9.4.1.1 Increasing incidence of DFUs to support market growth in China 84
9.4.2 JAPAN 86
9.4.2.1 Favorable regulations in Japan have boosted product launch and commercialization activity 86
9.4.3 INDIA 88
9.4.3.1 High rate of SSIs and growing investments indicate strong opportunities for market growth 88
9.4.4 AUSTRALIA 89
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support market growth 89
9.4.5 REST OF ASIA PACIFIC 91
_
9.5 LATIN AMERICA 93
9.5.1 BRAZIL 94
9.5.1.1 Brazil is the largest market for healthcare in the Latin American region 94
9.5.2 MEXICO 96
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico 96
9.5.3 REST OF LATIN AMERICA 97
9.6 MIDDLE EAST & AFRICA 98
9.6.1 GROWING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH 98

10 COMPETITIVE LANDSCAPE 101
10.1 INTRODUCTION 101
10.2 MARKET SHARE ANALYSIS, 2019 102
10.2.1 BIOFILMS TREATMENT MARKET, BY KEY PLAYER 102
10.2.2 BIOFILMS TREATMENT MARKET FOR HOSPITALS 103
10.2.3 BIOFILMS TREATMENT MARKET FOR HOME CARE SETTINGS 103
10.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 104
10.4 VENDOR INCLUSION CRITERIA 104
10.5 VENDOR DIVE 104
10.5.1 VISIONARY LEADERS 104
10.5.2 INNOVATORS 104
10.5.3 DYNAMIC DIFFERENTIATORS 104
10.5.4 EMERGING COMPANIES 105
10.6 COMPETITIVE SCENARIO 106
10.6.1 PRODUCT LAUNCHES & APPROVALS 106
10.6.2 ACQUISITIONS 107
10.6.3 COLLABORATIONS & PARTNERSHIPS 107

11 COMPANY PROFILES 108
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
11.1 SMITH AND NEPHEW PLC 108
11.2 MIMEDX GROUP 111
11.3 CONVATEC GROUP PLC 112
11.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 115
11.5 PAUL HARTMANN AG 118
11.6 M?LNLYCKE HEALTH CARE AB 120
11.7 COLOPLAST A/S 123
11.8 B. BRAUN MELSUNGEN AG 125
11.9 ORGANOGENESIS HOLDINGS INC. 127
11.10 MISONIX 129
11.11 ACELITY (A PART OF 3M) 131
11.12 ZIMMER BIOMET HOLDINGS INC. 133
11.13 KERECIS 134
11.14 MEDLINE INDUSTRIES, INC. 136
11.15 WELCARE INDUSTRIES S.P.A 137
11.16 MEDAXIS AG 138
11.17 PULSECARE MEDICAL 139
11.18 AROBELLA MEDICAL, LLC 140
11.19 ADVANCIS MEDICAL 141
11.20 RLS GLOBAL AB 142
11.21 MIL LABORATORIES PVT. LTD. 143
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX 144
12.1 DISCUSSION GUIDE 144
12.3 AVAILABLE CUSTOMIZATIONS 149
12.4 RELATED REPORTS 149
12.5 AUTHOR DETAILS 150



List of Figures



FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 22
FIGURE 3 BIOFILMS TREATMENT MARKET: BOTTOM-UP APPROACH 23
FIGURE 4 BIOFILMS TREATMENT MARKET: TOP-DOWN APPROACH 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 BIOFILMS TREATMENT MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 27
FIGURE 7 BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2020 VS. 2025 (USD MILLION) 28
FIGURE 8 BIOFILMS TREATMENT MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 28
FIGURE 9 BIOFILMS TREATMENT MARKET, BY REGION, 2020 VS. 2025 (USD MILLION) 29
FIGURE 10 INCREASING PREVALENCE OF CHRONIC, TRAUMATIC, AND SURGICAL WOUNDS WILL DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 30
FIGURE 11 GAUZES AND DRESSINGS WILL CONTINUE TO DOMINATE THE BIOFILMS TREATMENT MARKET DURING THE FORECAST PERIOD 31
FIGURE 12 HOSPITALS, ASCS, AND WOUND CARE CENTERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020 31
FIGURE 13 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 32
FIGURE 14 BIOFILMS TREATMENT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 33
FIGURE 15 INCIDENCE OF DIABETES, BY REGION, 2015 VS. 2040 (MILLION CASES) 34
FIGURE 16 NORTH AMERICA: BIOFILMS TREATMENT MARKET SNAPSHOT 64
FIGURE 17 ASIA PACIFIC: BIOFILMS TREATMENT MARKET SNAPSHOT 82
FIGURE 18 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE BIOFILMS TREATMENT MARKET 101
FIGURE 19 BIOFILMS TREATMENT MARKET SHARE, BY KEY PLAYER, 2019 102
FIGURE 20 BIOFILMS TREATMENT MARKET SHARE FOR HOSPITALS, BY KEY PLAYER, 2019 103
FIGURE 21 BIOFILMS TREATMENT MARKET SHARE FOR HOME CARE SETTINGS, BY KEY PLAYER, 2019 103
FIGURE 22 BIOFILMS TREATMENT MARKET (GLOBAL) COMPETITIVE LEADERSHIP
MAPPING, 2019 105
FIGURE 23 SMITH AND NEPHEW PLC: COMPANY SNAPSHOT (2019) 108
FIGURE 24 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2019) 112
FIGURE 25 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2019) 115
FIGURE 26 PAUL HARTMANN AG: COMPANY SNAPSHOT (2019) 118
FIGURE 27 M?LNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2018) 120
FIGURE 28 COLOPLAST A/S: COMPANY SNAPSHOT (2019) 123
FIGURE 29 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 125
FIGURE 30 ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2018) 127
FIGURE 31 MISONIX: COMPANY SNAPSHOT (2019) 129
FIGURE 32 ACELITY: COMPANY SNAPSHOT (2018) 131
FIGURE 33 ZIMMER BIOMET: COMPANY SNAPSHOT (2019) 133

 

List of Tables



TABLE 1 INCLUSIONS & EXCLUSIONS 17
TABLE 2 AVERAGE SELLING PRICE OF VARIOUS PRODUCTS USED IN THE BIOFILMS TREATMENT MARKET (USD) 38
TABLE 3 GLOBAL BIOFILMS TREATMENT MARKET BY PRODUCT, 2018–2025 (USD MILLION) 38
TABLE 4 DEBRIDEMENT EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 39
TABLE 5 NORTH AMERICA: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY 2018–2025 (USD MILLION) 40
TABLE 6 EUROPE: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY 2018–2025 (USD MILLION) 40
TABLE 7 APAC: DEBRIDEMENT EQUIPMENT MARKET, BY COUNTRY 2018–2025 (USD MILLION) 41
TABLE 8 GAUZES AND DRESSINGS MARKET, BY REGION, 2018–2025 (USD MILLION) 42
TABLE 9 NORTH AMERICA: GAUZES AND DRESSINGS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 42
TABLE 10 EUROPE: GAUZES AND DRESSINGS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 43
TABLE 11 APAC: GAUZES AND DRESSINGS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 43
TABLE 12 GRAFTS AND MATRICES MARKET, BY REGION, 2018–2025 (USD MILLION) 44
TABLE 13 NORTH AMERICA: GRAFTS AND MATRICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 44
TABLE 14 EUROPE: GRAFTS AND MATRICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 45
TABLE 15 APAC: GRAFTS AND MATRICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 45
TABLE 16 WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY REGION 2018–2025 (USD MILLION) 46
TABLE 17 NORTH AMERICA: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 46
TABLE 18 EUROPE: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 47
TABLE 19 APAC: WIPES, PADS, AND LAVAGE SOLUTIONS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 47
TABLE 20 GELS, OINTMENTS, AND SPRAYS MARKET, BY REGION 2018–2025 (USD MILLION) 48
TABLE 21 NORTH AMERICA: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 48
TABLE 22 EUROPE: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 49
TABLE 23 APAC: GELS, OINTMENTS, AND SPRAYS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 49
TABLE 24 BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION) 51
TABLE 25 BIOFILMS TREATMENT MARKET FOR SURGICAL AND TRAUMATIC WOUNDS BY REGION, 2018–2025 (USD MILLION) 52
TABLE 26 BIOFILMS TREATMENT MARKET FOR DIABETIC FOOT ULCERS, BY REGION 2018–2025 (USD MILLION) 53
TABLE 27 BIOFILMS TREATMENT MARKET FOR PRESSURE ULCERS, BY REGION 2018–2025 (USD MILLION) 54
TABLE 28 BIOFILMS TREATMENT MARKET FOR VENOUS LEG ULCERS, BY REGION 2018–2025 (USD MILLION) 55
TABLE 29 HOSPITAL ADMISSIONS FOR THE TREATMENT OF BURN INJURIES, 2015 55
TABLE 30 BIOFILMS TREATMENT MARKET FOR BURNS AND OTHER OPEN WOUNDS BY REGION, 2018–2025 (USD MILLION) 56
TABLE 31 BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 58
TABLE 32 BIOFILMS TREATMENT MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY REGION, 2018–2025 (USD MILLION) 59
TABLE 33 BIOFILMS TREATMENT MARKET FOR HOME CARE SETTINGS, BY REGION 2018–2025 (USD MILLION) 60
TABLE 34 BIOFILMS TREATMENT MARKET FOR OTHER END USERS, BY REGION 2018–2025 (USD MILLION) 60
TABLE 35 BIOFILMS TREATMENT MARKET, BY REGION, 2018–2025 (USD MILLION) 62
TABLE 36 NUMBER OF BIOFILM WOUND CASES, BY REGION, 2018–2025 (MILLION) 62
TABLE 37 NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY COUNTRY 2018–2025 (USD MILLION) 65
TABLE 38 NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 65
TABLE 39 NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 65
TABLE 40 NORTH AMERICA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 66
TABLE 41 US: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 67
TABLE 42 US: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION) 67
TABLE 43 US: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 67
TABLE 44 CANADA: INCIDENCE OF DIABETES, 2016 VS. 2026 68
TABLE 45 CANADA: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 68
TABLE 46 CANADA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 69
TABLE 47 CANADA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 69
TABLE 48 EUROPE: PREVALENCE OF DIABETES, 2015 VS. 2040 70
TABLE 49 EUROPE: BIOFILMS TREATMENT MARKET, BY COUNTRY 2018–2025 (USD MILLION) 70
TABLE 50 EUROPE: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 70
TABLE 51 EUROPE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 71
TABLE 52 EUROPE: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 71
TABLE 53 UK: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 72
TABLE 54 UK: BIOFILMS TREATMENT MARKET, BY WOUND TYPE, 2018–2025 (USD MILLION) 72
TABLE 55 UK: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 72
TABLE 56 GERMANY: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 73
TABLE 57 GERMANY: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 73
TABLE 58 GERMANY: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 74
TABLE 59 RUSSIA: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 74
TABLE 60 RUSSIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 75
TABLE 61 RUSSIA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 75
TABLE 62 FRANCE: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 76
TABLE 63 FRANCE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 76
TABLE 64 FRANCE: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 76
TABLE 65 ITALY: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 77
TABLE 66 ITALY: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 78
TABLE 67 ITALY: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 78
TABLE 68 SPAIN: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 79
TABLE 69 SPAIN: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 79
TABLE 70 SPAIN: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 79
TABLE 71 ROE: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 80
TABLE 72 ROE: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 80
TABLE 73 ROE: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 81
TABLE 74 APAC: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 75 APAC: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 83
TABLE 76 APAC: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 84
TABLE 77 APAC: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 84
TABLE 78 CHINA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 85
TABLE 79 CHINA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 85
TABLE 80 CHINA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 86
TABLE 81 JAPAN: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 87
TABLE 82 JAPAN: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 87
TABLE 83 JAPAN: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 87
TABLE 84 INDIA: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 88
TABLE 85 INDIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 88
TABLE 86 INDIA: BIOFILMS TREATMENT MARKET, BY END USER, 2018–2025 (USD MILLION) 89
TABLE 87 AUSTRALIA: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 90
TABLE 88 AUSTRALIA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 90
TABLE 89 AUSTRALIA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 90
TABLE 90 TOTAL DIABETES-RELATED HEALTH EXPENDITURE, 2019 VS. 2030 (USD MILLION) 91
TABLE 91 ROAPAC: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 91
TABLE 92 ROAPAC: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 92
TABLE 93 ROAPAC: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 92
TABLE 94 LATAM: BIOFILMS TREATMENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 95 LATAM: BIOFILMS TREATMENT MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 93
TABLE 96 LATAM: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 94
TABLE 97 LATAM: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 94
TABLE 98 BRAZIL: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 95
TABLE 99 BRAZIL: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 95
TABLE 100 BRAZIL: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 95
TABLE 101 MEXICO: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 96
TABLE 102 MEXICO: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 96
TABLE 103 MEXICO: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 97
TABLE 104 ROLATAM: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 97
TABLE 105 ROLATAM: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 98
TABLE 106 ROLATAM: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 98
TABLE 107 MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY PRODUCT 2018–2025 (USD MILLION) 99
TABLE 108 MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY WOUND TYPE 2018–2025 (USD MILLION) 99
TABLE 109 MIDDLE EAST & AFRICA: BIOFILMS TREATMENT MARKET, BY END USER 2018–2025 (USD MILLION) 100